Loading Map....


Date(s) - 25/06/2019 - 26/06/2019
4:30 pm


Macdonald Burlington Hotel Birmingham
Burlington Arcade, 126 New St
B2 4JQ


The 2nd Annual Scientific Meeting designed to advance scientific insights for PD specialists

‘Cutting Edge Science for Parkinson’s Clinicians’ is open to health professionals involved in the management and treatment of Parkinson’s disease (final year registrars and above).

This is the second meeting of its kind. Our first event took place in July 2018 (→ Programme).

→ Read more about our previous meeting



A draft programme will be available in the coming weeks on this page. The meeting will commence at 4.30 pm on Tuesday, 25 June and finish approx 5.00 pm on the 26 June.

Here is a sneak preview:

Prodromal Pd, Fact or Fiction?
Dr Alastair Noyce (Neurologist, Queen Mary University of London)
What have we learned from the GDNF trial?
Dr Alan Whone (Neurologist, University of Bristol)
How do dementia, psychosis and Pd overlap?
Prof Iracema Leroi (Old Age Psychiatrist, University of Manchester)
What is the relationship between Ageing, Frailty & Pd
Prof Richard Walker (Geriatrician, University of Newcastle)
How can we target the disease mechanisms in Parkinson’s disease?
Dr Simon Stott (Deputy Director of Research & Development Cure Parkinson’s Trust)


Confirmed guest speaker at the evening dinner will be Prof Bas Bloem, who is the founder and Medical Director of Parkinson Center Nijmegen and co-director of ParkinsonNet at Radboud University Medical Center in the Netherlands.


Costs & accommodation:

The event is fully funded and includes all meeting materials, an evening dinner with guest speaker Prof Bas Bloem, plus one night of accommodation on the 25 June, for non-local attendees.


Please note our terms and conditions.

If you have problems opening the online form due to a firewall or other network security system, please download the application form below or contact us info@neurologyacademy.org.

→ Download application form (PDF)


This meeting is designed and delivered by the Parkinson’s Academy and sponsored by Bial Pharma. The sponsor has had no input into the educational content or organisation of this meeting.